Patient P-02082
Synthetic patientMETA-24 · Day 175 · 55–64 · F · baseline S12Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
10%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S12
- Day 13 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 134 NP-02 recommended — Dietary Support Protocol NP-02
- Day 135 Patient accepted — Started NP-02 in the companion
- Day 145 GI symptom burden −13% vs expected — Dietary Support Protocol NP-02
- Day 151 Tolerance state changed — Unstable → Improving
What changed?
Trajectory began diverging from predicted response on Day 13.
Primary contributors, last 14 days
- GI instability-21
- Nutritional resilience+18
- Inflammatory activity-9
- Treatment adherence-4
- Toxicity+3
What helped?
- Dietary Support Protocol NP-02Day 134Result: symptom burden −13%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable87 min
stable · -0.9 vs previous 14 d
Sleep duration
Wearable7.1 h
stable · +0.1 vs previous 14 d
Energy level
Daily log6.2/10
stable · -0.1 vs previous 14 d
Steps
Wearable9,466
worsening · -522 vs previous 14 d
GI burden
Companion11.2/100
worsening · +1.8 vs previous 14 d
Adherence
Companion94.5 %
improving · +3.8 vs previous 14 d
Sleep quality
Wearable54.4/100
stable · -0.6 vs previous 14 d
Glucose, CGM daily mean
CGM125 mg/dL
stable · +3.6 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 76 from the failing basin, 26 from restoration.
Good elements to keep
- Dietary Support Protocol NP-02intervention · steering +17.5
- Protein (supports)perturbation · steering +12.6
- Butyrate producers intacthidden · steering +7.5
- Daily walks resumedperturbation · steering +3.3
- Proteinsupporter · GI -5.9 next day
Main detractors to watch
- Rapid metabolizerhidden · steering -8
- Enterobacteriaceae elevatedhidden · steering -7.4
- Poor-sleep weekperturbation · steering -3
- Low-HRV stretchperturbation · steering -2.7
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-5.9supporter · 95%
- Caffeine+2no signal · 38%
- Dietary fat load+1.8no signal · 38%
- Histamine load-1.7no signal · 33%
- Insoluble fibre-1.2no signal · 21%
- Alcohol-0.9no signal · 19%
- Simple carbohydrates+0.4no signal · 15%
- Ultra-processed food+0.4no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
DNA
Fictional pharmacogenomic panel
- CYP2D6 Rapid metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.4 · butyrate capacity 60/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 53 ms
- Sleep
- 6.8 h
- Steps
- 9,095
- Resting HR
- 64 bpm
Daily log: GI score 11, nutritional resilience 69, adherence 95.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02462 | 45% | S12 | DT-01 | improved | 65 |
| P-02303 | 42% | S15 | GI-04 | improved | 48 |
| P-02441 | 42% | S11 | SC-12 | improved | 67 |
| P-02620 | 42% | S01 | HY-01 | improved | 64 |
| P-02685 | 42% | S16 | DT-01 | improved | 47 |
| P-02586 | 41% | S18 | DT-01 | improved | 56 |
| P-02147 | 40% | S13 | GI-04 | improved | 58 |
| P-02235 | 40% | S14 | DT-01 | improved | 50 |
| P-02064 | 39% | S04 | SC-12 | improved | 57 |
| P-02339 | 39% | S03 | DT-01 | improved | 50 |
| P-02167 | 38% | S02 | HY-01 | improved | 54 |
| P-02355 | 38% | S09 | GI-04 | improved | 55 |